Chief Regulatory Officer
Dr. Marie Deneux is in charge of defining and executing the regulatory strategy for the development and registration of Lysogene’s gene therapy products. Prior to joining Lysogene, Dr. Deneux was Senior Director, Regulatory Science, Drugs and Biologics at Voisin Consulting Life Sciences, where she spent 15 years assisting life sciences companies throughout the development, registration and lifecycle of their products. Involved in the development of biotechnology products, new chemical entities, cell and gene therapy drugs and repurposed drugs, she has extensive experience in interactions with the European Medicines Agency (EMA), national European health authorities and the Food and Drug Administration (FDA).
Dr. Deneux received an engineering degree from AgroParisTech (formerly INA-PG, Institut National Agronomique Paris-Grignon), completed by her Ph.D in cellular and molecular pharmacology at the French National Center for Scientific Research (CNRS).